110 related articles for article (PubMed ID: 18395383)
1. [Demographic, clinical, immunovirological and therapeutic features of 8714 HIV infected French patients included in the Nadis Hospital Cohorte in 2006].
de la Tribonnière X; Pugliese P; Cabié A; Cuzin L; Billaud E; Poizot-Martin I; Duvivier C; Yazdanpanah Y;
Med Mal Infect; 2008 Jun; 38(6):299-308. PubMed ID: 18395383
[TBL] [Abstract][Full Text] [Related]
2. [Medical care for HIV infection in France in 2005, the NADIS cohort study on 7416 patients].
Poizot-Martin I; Pugliese P; Enel P; Cuzin L; Billaud E; Duvivier C; Yazdanpanah Y;
Med Mal Infect; 2006 Sep; 36(9):454-9. PubMed ID: 17030485
[TBL] [Abstract][Full Text] [Related]
3. A large French prospective cohort of HIV-infected patients: the Nadis Cohort.
Pugliese P; Cuzin L; Cabié A; Poizot-Martin I; Allavena C; Duvivier C; El Guedj M; de la Tribonnière X; Valantin MA; Dellamonica P;
HIV Med; 2009 Sep; 10(8):504-11. PubMed ID: 19486189
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France.
Breton G; Lewden C; Spire B; Salmon D; Brun-Vézinet F; Duong M; Allavena C; Leport C; Salamon R;
HIV Med; 2007 Apr; 8(3):164-70. PubMed ID: 17461860
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and sexual risk of hepatitis C virus infection when human immunodeficiency virus was acquired through sexual intercourse among patients of the Lyon University Hospitals, France, 1992-2002.
D'Oliveira A; Voirin N; Allard R; Peyramond D; Chidiac C; Touraine JL; Fabry J; Trepo C; Vanhems P
J Viral Hepat; 2005 May; 12(3):330-2. PubMed ID: 15850476
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology, clinical and laboratory characteristics of currently alive HIV-1 infected former blood donors naive to antiretroviral therapy in Anhui Province, China.
Xu JQ; Wang JJ; Han LF; Xu C; Ruan YH; Xu ZH; Chen X; Liu ZD; Wang J; Su B; Ding XP; Gao B; Gu YB; Cao XY; Xing H; Hong KX; Peng H; Zhao QB; Yuan L; Feng Y; Zhang GY; Ma LY; Wu L; Shao YM
Chin Med J (Engl); 2006 Dec; 119(23):1941-8. PubMed ID: 17199937
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and survival of HIV-infected patients not screened for hepatitis C virus infection in a hospital-based cohort.
Bénet T; D'Oliveira A; Voirin N; Livrozet JM; Cotte L; Peyramond D; Chidiac C; Touraine JL; Fabry J; Trepo C; Allard R; Vanhems P
J Viral Hepat; 2007 Oct; 14(10):730-5. PubMed ID: 17875008
[TBL] [Abstract][Full Text] [Related]
8. The impacts of current antiretroviral therapy regimens on Chinese AIDS patients and their implications for HIV-1 drug resistance mutation.
Zhang M; Han XX; Cui WG; Jia MH; Meng XD; Xing AH; Wu YH; Yang YY; Lu CM; Hu QH; Dai D; Zhang ZN; Shang H
Jpn J Infect Dis; 2008 Sep; 61(5):361-5. PubMed ID: 18806342
[TBL] [Abstract][Full Text] [Related]
9. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
10. Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy.
Piketty C; Selinger-Leneman H; Grabar S; Duvivier C; Bonmarchand M; Abramowitz L; Costagliola D; Mary-Krause M;
AIDS; 2008 Jun; 22(10):1203-11. PubMed ID: 18525266
[TBL] [Abstract][Full Text] [Related]
11. Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study.
Omland LH; Weis N; Skinhøj P; Laursen A; Christensen PB; Nielsen HI; Møller A; Engsig F; Sørensen HT; Obel N
HIV Med; 2008 May; 9(5):300-6. PubMed ID: 18400077
[TBL] [Abstract][Full Text] [Related]
12. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR;
Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328
[TBL] [Abstract][Full Text] [Related]
13. Outcome and prognosis factors in HIV-infected hemodialysis patients.
Tourret J; Tostivint I; du Montcel ST; Bragg-Gresham J; Karie S; Vigneau C; Guiard-Schmid JB; Deray G; Bagnis CI
Clin J Am Soc Nephrol; 2006 Nov; 1(6):1241-7. PubMed ID: 17699354
[TBL] [Abstract][Full Text] [Related]
14. Sexual transmission is associated with spontaneous HCV clearance in HIV-infected patients.
Shores NJ; Maida I; Soriano V; Núnez M
J Hepatol; 2008 Sep; 49(3):323-8. PubMed ID: 18486266
[TBL] [Abstract][Full Text] [Related]
15. Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.
Soria A; Porten K; Fampou-Toundji JC; Galli L; Mougnutou R; Buard V; Kfutwah A; Vessière A; Rousset D; Teck R; Calmy A; Ciaffi L; Lazzarin A; Gianotti N
Antivir Ther; 2009; 14(3):339-47. PubMed ID: 19474468
[TBL] [Abstract][Full Text] [Related]
16. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
Cohen Stuart JW; Velema M; Schuurman R; Boucher CA; Hoepelman AI
J Med Virol; 2009 Mar; 81(3):441-5. PubMed ID: 19152397
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi.
Nyirenda M; Beadsworth MB; Stephany P; Hart CA; Hart IJ; Munthali C; Beeching NJ; Zijlstra EE
J Infect; 2008 Jul; 57(1):72-7. PubMed ID: 18555534
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection drug users at a referral hospital.
Liang SH; Lo YC; Lin HH; Chang SY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Hung CC; Chang SC
J Microbiol Immunol Infect; 2008 Jun; 41(3):200-8. PubMed ID: 18629414
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study).
Diop-Ndiaye H; Touré-Kane C; Etard JF; Lô G; Diaw P; Ngom-Gueye NF; Gueye PM; Ba-Fall K; Ndiaye I; Sow PS; Delaporte E; Mboup S
J Med Virol; 2008 Aug; 80(8):1332-6. PubMed ID: 18551596
[TBL] [Abstract][Full Text] [Related]
20. New Zealand's HIV infected population under active follow-up during 2000.
Mills G; Yardley AM; Thomas M; Blackmore T; Pithie A; Schroeder B; Dickson N
N Z Med J; 2002 Apr; 115(1152):173-6. PubMed ID: 12043998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
